Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2 : an interrupted time-series analysis
Authors:ID Lenglart, Léa (Author)
ID Özmen, Izel (Author)
ID Aguilera-Alonso, David (Author)
ID Blazquez-Gamero, Daniel (Author)
ID Boeddha, Navin P. (Author)
ID Buddingh, Emilie Pauline (Author)
ID Buonsenso, Danilo (Author)
ID Plankar Srovin, Tina (Author)
ID Vincek, Katarina (Author)
ID Pokorn, Marko (Research coworker)
ID Seme, Katja (Research coworker)
ID Velimirović, Ivana (Research coworker), et al.
Files:.pdf PDF - Presentation file, download (3,01 MB)
MD5: 1ADBD04753ED7D3DAF5E4E44AF4A33DF
 
URL URL - Source URL, visit https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00289-3/fulltext
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background: After lifting non-pharmaceutical interventions (NPIs) against the transmission of SARS-CoV-2, various countries experienced an increase in invasive Group A Streptococcal (iGAS) infections. We aimed to characterise the paediatric outbreak across Europe and to analyse the influence of viral infections. Methods: We conducted an interrupted time-series analysis based on data from 15 European countries from the PEGASUS consortium. We assessed the evolution of the number of iGAS cases aged 1 month to 18 years between 01/01/2018 and 03/31/2024, comparing the post-NPIs period (01-04-2022 until 31-03-2024) to the baseline period (01-01-2018 until 31-03-2020). Further analyses were performed by country, clinical phenotype, age and severity, including sensitivity analyses. We then explored whether certain iGAS phenotypes correlated with trends in RSV, influenza and VZV across countries over time using Google Trends data. Findings: We included 2091 iGAS cases over the study period; 79 children (3.6%) died and 580 (27.7%) required PICU admission. We estimated an overall increase of +229.8% (95% CI (141.9-341.6)) among iGAS cases from October 2022 to March 2024, compared to the baseline period. The observed increases varied across clinical phenotypes, ranging from +62.7% (95% CI (8.3-157.9)) for osteo-articular infections to +238.7% (95% CI 75.8-464.8) for pneumonia. We observed a strong correlation between the incidence of iGAS pneumonia and RSV (Rho: 0.57, 95% CI [0.11-0.79]) and influenza (Rho 0.69, 95% CI 0.35-0.87); and between skin and soft tissue infections and VZV (Rho: 0.73, 95% CI [0.42-0.89]). Interpretation: The patterns observed across Europe during this outbreak demonstrate an association between respiratory viruses as well as VZV, and iGAS.
Keywords:Streptococcus pyogenes, group A streptococcus, invasive streptococcal disease, outbreak, paediatrics, viral infections, viruses, influenza, flu, RSV, respiratory syncytial virus, VZV, varicella, immunity debt, non pharmaceutical interventions
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 1-14
Numbering:Vol. 59, [article no.] 101497
PID:20.500.12556/DiRROS-24687 New window
UDC:616.9
ISSN on article:2666-7762
DOI:10.1016/j.lanepe.2025.101497 New window
COBISS.SI-ID:255909891 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 5. 11. 2025;
Publication date in DiRROS:12.12.2025
Views:37
Downloads:16
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:The Lancet regional health : Europe
Publisher:Elsevier Ltd.
ISSN:2666-7762
COBISS.SI-ID:56262915 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back